OIS at AAO 2015

Spark Therapeutics

Nov 12, 2015 4:20pm ‐ Nov 12, 2015 4:30pm


Spark Therapeutics (NASDAQ: ONCE) is a gene therapy leader seeking to transform the lives of patients with debilitating genetic diseases through one-time, life-altering treatments. Spark’s initial focus is on orphan diseases, including inherited forms of blindness, hemophilia, and other conditions. Our integrated platform is built on two decades of research, development and manufacturing at The Children’s Hospital of Philadelphia.


You must be logged in and own this session in order to post comments.